Login / Signup

Clinical and transcriptomic features of persistent exacerbation-prone severe asthma in U-BIOPRED cohort.

Uruj HodaStelios PavlidisAruna T BansalKentaro TakahashiSile HuFrancois Ng Kee KwongChristos RossiosKai SunPankaj BhavsarMatthew LozaFrederic BaribaudPascal ChanezStephen J FowlerIldiko HorvathPaolo MontuschiFlorian SingerJacek MusialBarbro DahlenNorbert KrugThomas SandstromDominic E ShawRene LutterLouise J FlemingPeter H HowarthMassimo CarusoAna R SousaJulie CorfieldCharles AuffrayBertrand De MeulderDiane LefaudeuxSven-Erik DahlenRatko DjukanovicPeter J SterkYike GuoIan M AdcockKian Fan Chungnull null
Published in: Clinical and translational medicine (2022)
The FE group and its PFE subgroup are associated with poor asthma control while expressing higher type 1 and type 2 activation pathways compared to IE and PIE, respectively.
Keyphrases
  • chronic obstructive pulmonary disease
  • lung function
  • single cell
  • rna seq
  • randomized controlled trial
  • clinical trial
  • air pollution
  • study protocol
  • open label